|
PPA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.709770E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.373410E-01 |
| Normal-vs-Stage2 |
7.290400E-01 |
| Normal-vs-Stage3 |
3.079800E-01 |
| Normal-vs-Stage4 |
7.714400E-02 |
| Stage1-vs-Stage2 |
1.323980E-01 |
| Stage1-vs-Stage3 |
7.898200E-01 |
| Stage1-vs-Stage4 |
5.101800E-01 |
| Stage2-vs-Stage3 |
2.535800E-01 |
| Stage2-vs-Stage4 |
9.346300E-02 |
| Stage3-vs-Stage4 |
4.320600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.395990E-01 |
| Normal-vs-AfricanAmerican |
4.946200E-01 |
| Normal-vs-Asian |
9.680200E-03 |
| Caucasian-vs-AfricanAmerican |
8.133200E-01 |
| Caucasian-vs-Asian |
1.250160E-01 |
| AfricanAmerican-vs-Asian |
1.530760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.961800E-02 |
| Normal-vs-Female |
2.978000E-01 |
| Male-vs-Female |
2.485000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.918400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.733590E-01 |
| Normal-vs-Age(61-80Yrs) |
8.587000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.481200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.660600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.343020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.518800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.508800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.522000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.807000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.590400E-01 |
| Classical-VS-Follicular |
2.873500E-02 |
| Classical-VS-Other |
3.467800E-01 |
| Classical-VS-Normal |
5.721800E-02 |
| Tall-VS-Follicular |
5.786200E-01 |
| Tall-VS-Other |
1.274180E-01 |
| Tall-VS-Normal |
9.006800E-01 |
| Follicular-VS-Other |
1.585550E-01 |
| Follicular-VS-Normal |
5.903600E-01 |
| Other-VS-Normal |
5.997900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.477000E-01 |
| Normal-vs-N1 |
2.298200E-03 |
| N0-vs-N1 |
1.593880E-02 |
|
|
